Superworth

Zoetis EV/EBIT ZTS

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2014.

Today, Oct 23, 2026
11.6×
10-year median
26.8×
Against its 10-year history
4th
percentile: 0 is its lowest day, 100 its highest
10-year range
10.3× to 44.2×
Peer median
27.1×

Zoetis' EV/EBIT is 11.6× as of Oct 23, 2026.

That is below its ten-year median of 26.8×, lower than on 96% of days in the last ten years.

Over that time it ranged from 10.3× in Oct 2026 to 44.2× in Dec 2021.

The median for 10 healthcare stocks of a similar size is 27.1×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far11.6×10.3×17.2×
202517.1×16.1×24.8×
202423.9×22.4×30.6×
202330.4×24.8×32.0×
202225.7×23.5×38.4×
202144.2×31.9×44.2×
202035.9×25.2×37.2×
201934.3×23.0×34.4×
201822.9×22.3×28.5×
201725.9×21.5×26.0×
201624.6×21.4×27.8×
201524.9×22.8×28.0×
201426.0×20.7×26.4×

Against its peers

Companies in Healthcare nearest Zoetis' size, closest first, today.

CompanyEV/EBIT
ZTSZoetis11.6×
MTDMettler-Toledo International30.5×
CNCCentene21.8×
GEHCGE HealthCare Technologies14.7×
RMDResMed18.7×
RPRXRoyalty Pharma30.2×
BIIBBiogen26.3×
ALNYAlnylam Pharmaceuticals27.9×
DXCMDexCom25.3×
WSTWest Pharmaceutical Services39.5×
ILMNIllumina47.7×
Peer median27.1×

Where Zoetis ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Zoetis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.